 |
2 Products |  |
1 Disease | | 2 Products |
|
1 Trial |  |
39 News |  |
| «12 |
- ||||| BTRX-246040 / BlackThorn Therap
New P2 trial: Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD) (clinicaltrials.gov) - Nov 7, 2012
P2, N=120, Completed, Sponsor: Eli Lilly and Company
- | BTRX-246040 / Neumora Therap
Trial completion: A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects (clinicaltrials.gov) - Jan 22, 2012
P1, N=20, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Completed
- | BTRX-246040 / Neumora Therap
Trial completion: A Study of LY2940094 in Major Depressive Disorder (clinicaltrials.gov) - Nov 13, 2011
P1, N=50, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Completed Active, not recruiting --> Completed